In line with this, NAD+ augmentation, via supplementation with nicotinamide riboside, reduces senescence and improves mitochondrial metabolic profiles in MSCs with WRN knockout (WRN−/−) and in primary fibroblasts derived from WS patients compared to controls. The gene discussed is WRN; the disease is Werner syndrome.